Delivery Order SPE2DB20D1004-SPE2DB22FF4N0
Award Date 4/1/22
Potential Completion Date 4/4/22
Potential Value $4.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,561,559,448 tablets of Mesalamine DR 1.2 GM. The total ceiling value of the delivery order is $3,846.35, with a firm fixed price. The contract has an ultimate completion date of July 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.43 firm fixed-price delivery order is for the supply of 4,561,731,416 units of Mesalamine DR 1.2 GM Tablets in quantities of 120 per bottle. The contract has an ultimate completion date of August 8, 2023 and was awarded on August 7, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 1.2 GM Tablets. The contract has a ceiling value of $1,810.32 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine DR 1.2 GM tablets, with a ceiling value of $1,095.96 and a period of performance through November 29, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and holds several Indefinite Delivery Contracts...
- The Defense Logistics Agency awarded a delivery order valued at $1,940.56 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 28, 2026, and was competitively awarded with no set-aside designation. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,180.22 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,562,817,232 units of the drug Mesalamine DR 1.2 GM Tablet 120S. The contract has an ultimate completion date of November 15, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,608.15 firm fixed-price delivery order, with a completion date of December 28, 2021, is for the supply of Mesalamine DR 1.2 GM Tablet 120S, a prescription medication. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine DR 1.2 GM tablets, a medication used to treat certain gastrointestinal conditions. The contract has a firm fixed price of $6,083.81 and a completion date of July 3, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract provides for the delivery of Mesalamine delayed-release 1.2 gram tablets. The contract has a ceiling value of $4,625.78 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award. The contract is not set-aside for any socioeconomic...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mesalamine 800 mg delayed-release (DR) tablets. The contract has a ceiling value of $9,424.34 and an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). This contract...